FGF21 and the detection of dietary protein restriction
Active Grant Awarded
- Award ID
- R01DK144477
- Recipient
-
Pennington Biomedical Research Center UEI MWYVQTQ32ME5
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $503,295
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date 5% complete
- Place of performance
- Baton Rouge, LA 70808, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases awarded Pennington Biomedical Research Center a grant (Grant R01DK144477) on September 9, 2026, with $503,295 obligated under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The funded project studies FGF21, a liver-derived hormone that signals dietary protein restriction to the brain. It focuses on a population of KLB-expressing neurons in the hindbrain, which the recipient's data indicate are required for the changes in energy expenditure and food intake that accompany protein restriction. The work will functionally probe how these neurons affect metabolism and behavior as nutritional state changes. The program's stated purpose is extramural basic and clinical research on diabetes, digestive, and kidney diseases, and its programmatic areas include nutrition and obesity. The period of performance runs from September 9, 2026 to May 31, 2030, and work is performed in Baton Rouge, Louisiana 70808.
Description
- Abstract
- Survival is contingent upon physiologically and behaviorally adapting to a changing nutritional environment. The liver-derived hormone FGF21 acts in the brain as a signal of dietary protein restriction, allowing animals to adaptively 'sense' their nutritional state and respond by specifically seeking and consuming protein. Low protein (LP) diets increase energy expenditure, remodel adipose tissue, extend lifespan, and increase the motivation to procure and consume protein. Our work demonstrates that the deletion of FGF21, or brain- specific deletion of its obligate CO-receptor beta-klotho (KLB), completely abrogates these physiological responses. This project focuses specifically on a population of KLB-expressing neurons within the hindbrain, since our data indicate that deleting these neurons blocks the changes in energy expenditure and food intake that normally accompany dietary protein restriction. Therefore, this population of FGF21-responsive neurons plays a key role in the adaptive response to protein restriction, and this project seeks to functionally probe the mechanisms through which they impact metabolism and behavior in response to altered nutritional state.
Quick answers
Who received award R01DK144477?
R01DK144477 was awarded to Pennington Biomedical Research Center by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 9, 2026.
How much is award R01DK144477 worth?
$503,295 has been obligated on R01DK144477.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award